Trial
NCT00717522
Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Celgene
Collaborators
—
Condition
Soft Tissue Sarcoma
Intervention
Pomalidomide
Why stopped
Study enrollment was terminated due to a corporate strategic decision unrelated to patient safety.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-19